Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor

doi:10.1084/jem.166.4.1156

This Article

	Full Text (PDF, 390K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Lowenthal, J. W.
	Articles by Greene, W. C.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Lowenthal, J. W.
	Articles by Greene, W. C.


Social Bookmarking

	What's this?

ARTICLES

Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor

JW Lowenthal and WC Greene
Howard Hughes Medical Institute, Department of Internal Medicine, Duke University School of Medicine, Durham, North Carolina 27710.

In this report, we have investigated the kinetics of IL-2 binding to the alpha (p55) and beta (p70) IL-2 binding proteins and compared these properties with ligand binding to the high-affinity IL-2-R. The association and dissociation of IL-2 to the alpha (p55) chain occurred with very rapid kinetics (t 1/2 = 4-10 s). In contrast, IL-2 association to, and dissociation from the beta (p70) chain occurred at a greatly reduced rate (t 1/2 = 40-50 min and 200-400 min, respectively). Measurements of IL-2 binding to the high-affinity receptor revealed an interesting composite of these binding properties with a rapid association rate (t 1/2 = 30-45 s) resembling the alpha (p55) chain and a slow dissociation rate (t 1/2 = 270-300 min) similar to the beta (p70) chain. These findings provide additional support for the model of the high-affinity IL-2-R as a heterodimeric membrane complex composed of both the alpha (p55) and beta (p70) subunits and suggest that high-affinity IL-2 binding may involve a conformational change in structure of either or possibly both of the receptor chains. These results highlight the important and perhaps different role played by each subunit in the formation of functional high-affinity IL-2-R.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Aman, M. J., Tayebi, N., Obiri, N. I., Puri, R. K., Modi, W. S., Leonard, W. J. (1996). cDNA Cloning and Characterization of the Human Interleukin 13Receptor alpha Chain. J. Biol. Chem. 271: 29265-29270 [Abstract] [Full Text]
Tsytsikov, V. N., Yurovsky, V. V., Atamas, S. P., Alms, W. J., White, B. (1996). Identification and Characterization of Two Alternative Splice Variants of Human Interleukin-2. J. Biol. Chem. 271: 23055-23060 [Abstract] [Full Text]
Liu, K. D., Lai, S. Y., Goldsmith, M. A., Greene, W. C. (1995). Identification of a Variable Region within the Cytoplasmic Tail of the IL-2 Receptor beta Chain That Is Required for Growth Signal Transduction. J. Biol. Chem. 270: 22176-22181 [Abstract] [Full Text]
Subtil, A, Hemar, A, Dautry-Varsat, A (1994). Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited. J. Cell Sci. 107: 3461-3468 [Abstract]
Tigges, M., Casey, L., Koshland, M. (1989). Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 243: 781-786 [Abstract]
Van Kerckhove, C. W., Ceuppens, J. L., Vanderschueren-Lodeweyckx, M., Eggermont, E., Vertessen, S., Stevens, E. A. M. (1988). Bloom's Syndrome: Clinical Features and Immunologic Abnormalities of Four Patients. Arch Pediatr Adolesc Med 142: 1089-1093 [Abstract]
Smith, K. (1988). Interleukin-2: inception, impact, and implications. Science 240: 1169-1176 [Abstract]